Ventas (VTR) FY2025 results: revenue $5.8 billion, up 18.5% on the year
Ventas, Inc. (VTR) reported revenue of $5.8 billion for fiscal 2025, the year ended 31 December 2025, up 18.5% on the year before. Net income was $251 million, up 209.8%, and diluted earnings per share $0.54. The figures are the company's own, from the 10-K it filed with the SEC on 6 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 12 new.
- Fourth-quarter Normalized FFO up 10%: Fourth-quarter Normalized FFO was $0.89 per share, up approximately 10%. Attributable Net Income was $0.15, against $0.13 in the fourth quarter of 2024.
- NOI grew 16% for the year: Total Company NOI grew 16% for the full year and 15% in the fourth quarter. Total Company Same-Store Cash NOI grew 8% in both periods.
- SHOP same-store NOI up over 15%: SHOP Same-Store Cash NOI grew over 15% for the year, led by 18% growth in the U.S. portfolio. The fourth quarter also grew over 15%.
- SHOP occupancy up 300 basis points: Year-over-year average occupancy in SHOP grew 300 basis points in the fourth quarter. RevPOR growth was also reported.
- Net debt to EBITDA fell to 5.2x: Net debt to Further Adjusted EBITDA was 5.2x at year end, against 5.3x at September 30, 2025 and 6.0x a year earlier. Management cited SHOP growth and equity-funded investments.
From this 10-K
Ventas owns senior housing communities, outpatient medical buildings, research centres, hospitals and healthcare facilities in North America and the United Kingdom. It has been taxed as a REIT since its 1999 taxable year. Head office is in Chicago, with further corporate offices in Louisville and New York.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 5,834 | 4,924 | 4,498 | +18.5% | |
| Operating income | 204 | -8.0 | -116 | ||
| Operating margin | 3.5% | -0.2% | -2.6% | ||
| Interest expense | 612 | 603 | 574 | +1.6% | |
| Pre-tax income | 204 | -8.0 | -116 | ||
| Income tax | -14.2 | -37.8 | -9.5 | ||
| Effective tax rate | -6.9% | n/a | n/a | ||
| Net income | 251 | 81.2 | -41.0 | +209.8% | |
| Net margin | 4.3% | 1.6% | -0.9% | ||
| Diluted EPS | $0.54 | $0.19 | -$0.10 | +184.2% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 1,647 | 1,330 | 1,120 | +23.8% | |
| Capital expenditure | 2,928 | 2,530 | 649 | +15.7% | |
| Free cash flow | -1,281 | -1,200 | 470 | ||
| Free cash flow margin | -22.0% | -24.4% | 10.5% | ||
| Cash from investing | -2,694 | -2,377 | -185 | ||
| Cash from financing | 874 | 1,445 | -544 | -39.5% | |
| Depreciation and amortisation | 1,379 | 1,253 | 1,392 | +10.1% | |
| Share-based compensation | 38.7 | 31.0 | 31.0 | +25.0% | |
| Dividends paid | 860 | 740 | 724 | +16.2% | |
| Dividend per share | $1.92 | $1.80 | $1.80 | +6.7% | |
| Diluted shares, weighted | 463m | 416m | 406m | +11.1% | |
| Shares outstanding at period end | 475m | 437m | 402m | +8.7% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 12,527 | 10,771 | 9,488 | +16.3% | |
| Non-controlling interest | 58.6 | 58.3 | 56.3 | +0.4% | |
| Redeemable equity | 375 | 310 | 303 | +20.9% | |
| Debt | 13,011 | 13,523 | 13,491 | -3.8% | |
| Other liabilities | 1,620 | 1,525 | 1,387 | +6.3% | |
| Total liabilities and equity | 27,592 | 26,187 | 24,725 | +5.4% | |
| Goodwill | 1,046 | 1,045 | 1,045 | +0.1% | |
| Cash and equivalents | 741 | 898 | 509 | -17.5% | |
| Receivables | 99.9 | 108 | 76.1 | -7.6% | |
| Other assets | 25,705 | 24,136 | 23,095 | +6.5% | |
| Total assets | 27,592 | 26,187 | 24,725 | +5.4% |
10-K for the year ended 31 December 2025, filed 6 February 2026: the filing.